Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Dec 10, 2014; 5(5): 921-930
Published online Dec 10, 2014. doi: 10.5306/wjco.v5.i5.921
Published online Dec 10, 2014. doi: 10.5306/wjco.v5.i5.921
Table 4 Summary of clinical outcomes in published results for image-based brachytherapy for cervical cancer
| Local control | Disease free survival | Overall survival | Late toxicity (G3+) | |
| STIC[47] (2-yr) | 78.5%-100% | 60.3%-89.7% | 74%-96% | 2.6%-8.9% |
| Vienna[39] (3-yr) | 95% | 74% | 68% | 7.7% crude |
| Pittsburgh[48] (2-yr) | 90% | NR | 82% | 2% |
| Paris[49] (4-yr) | 91% | 86% | 94% | 0% |
| Addenbrooke[41] (3-yr) | 96% | 81% | 82% | 11% crude (14% actuarial) |
| Australia[50] (5-yr) | 87%-88% | 67% | 60% | 0.6%-4.6% |
| Korea[51] (3-yr) | 97% | 80% | NR | 2% |
- Citation: Vargo JA, Beriwal S. Image-based brachytherapy for cervical cancer. World J Clin Oncol 2014; 5(5): 921-930
- URL: https://www.wjgnet.com/2218-4333/full/v5/i5/921.htm
- DOI: https://dx.doi.org/10.5306/wjco.v5.i5.921